Literature DB >> 22315177

Leukoencephalopathy after levamisole for the treatment of verrucae.

Yu-Chen Cheng1, Helen L Po.   

Abstract

PURPOSE: Levamisole is an antihelmintic and immunomodulator used as a dewormer and in combination with other forms of chemotherapy to treat colon cancer, melanoma, and head and neck cancer. It has also been used for treating dermatologic disorders such as verrucae. However, its benefits remain controversial and serious side effects such as central nervous system toxicity are unexpected. CASE REPORT: Multifocal leukoencephalopathy developed in a 26-year-old man after levamisole treatment for verrucae. He recovered completely after discontinuation of the offending drug and treatment with steroid and plasmapheresis.
CONCLUSION: Clinicians should be aware of this neurotoxicity in order to provide early diagnosis and treatment and thereby improve outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22315177

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  3 in total

1.  Cocaine-induced toxic leucoencephalopathy with complete clinical recovery.

Authors:  Ylenia Abdilla; Marija Cauchi; Norbert Vella
Journal:  BMJ Case Rep       Date:  2019-07-27

Review 2.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

Review 3.  Multifocal leukoencephalopathy in cocaine users: a report of two cases and review of the literature.

Authors:  Reza Vosoughi; Brian J Schmidt
Journal:  BMC Neurol       Date:  2015-10-19       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.